CT47A11

gene
On this page

Also known as CT47.11

Summary

CT47A11 (cancer/testis antigen family 47 member A11, HGNC:27397) is a protein-coding gene on chromosome Xq24, encoding Cancer/testis antigen 47A (Q5JQC4).

This locus represents a member of the cancer/testis gene family 47. This family, also known as CT47, is comprised of 13 nearly identical loci clustered at Xq24.

Source: NCBI Gene 255313 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_173571

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27397
Approved symbolCT47A11
Namecancer/testis antigen family 47 member A11
LocationXq24
Locus typegene with protein product
StatusApproved
AliasesCT47.11
Ensembl geneENSG00000226929
Ensembl biotypeprotein_coding
OMIM300592
Entrez255313

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000457020

RefSeq mRNA: 1 — MANE Select: NM_173571 NM_173571

CCDS: CCDS35381

Canonical transcript exons

ENST00000457020 — 3 exons

ExonStartEnd
ENSE00001737067120935119120935274
ENSE00001839061120933840120933980
ENSE00001891561120936162120937158

Expression profiles

Bgee: expression breadth broad, 12 present calls, max score 86.47.

Top tissues by expression

127 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099186.47gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047375.65silver quality
right testisUBERON:000453454.20gold quality
testisUBERON:000047353.33gold quality
left testisUBERON:000453353.00gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
ganglionic eminenceUBERON:000402335.49gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
muscle tissueUBERON:000238531.06gold quality
sural nerveUBERON:001548830.93gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.19gold quality
placentaUBERON:000198729.10gold quality
liverUBERON:000210728.49gold quality
duodenumUBERON:000211428.14gold quality
lymph nodeUBERON:000002927.57gold quality
tonsilUBERON:000237227.05gold quality
islet of LangerhansUBERON:000000626.55gold quality
vermiform appendixUBERON:000115426.42gold quality
leukocyteCL:000073826.10gold quality
gall bladderUBERON:000211025.98gold quality
monocyteCL:000057625.95gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
urinary bladderUBERON:000125525.72gold quality
adrenal tissueUBERON:001830325.39gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-36552yes62.36
E-GEOD-134144yes31.23
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

14 targeting CT47A11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-569699.9872.364487
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-6505-5P99.7369.251595
HSA-MIR-129099.5969.902079
HSA-MIR-190A-5P99.5471.45933
HSA-MIR-190B-5P99.5471.40925
HSA-MIR-1212399.5271.792990
HSA-MIR-664A-3P99.2271.082696
HSA-MIR-653-3P98.3167.711542
HSA-MIR-6773-3P98.1765.511213
HSA-MIR-6839-5P96.7468.291088
HSA-MIR-378J96.4466.201020
HSA-MIR-6760-3P96.3568.311001

Literature-anchored findings (GeneRIF, showing 1)

  • CT47 expression was found in approximately 15% of lung cancer and esophageal cancer specimens, but not in colorectal cancer or breast cancer. The putative CT47 protein consists of 288 amino acid, with a C-terminus rich in alanine and glutamic acid. (PMID:16382448)

Cross-species orthologs

0 orthologs

Paralogs (13): CT47A10 (ENSG00000224089), CT47A6 (ENSG00000226023), CT47A9 (ENSG00000226600), CT47A12 (ENSG00000226685), CT47A7 (ENSG00000228517), CT47A8 (ENSG00000230347), CT47A4 (ENSG00000230594), CT47A3 (ENSG00000236126), CT47A1 (ENSG00000236371), CT47B1 (ENSG00000236446), CT47A5 (ENSG00000237957), CT47A2 (ENSG00000242362), CT47C1 (ENSG00000277535)

Protein

Protein identifiers

Cancer/testis antigen 47AQ5JQC4 (reviewed: Q5JQC4)

Alternative names: Cancer/testis antigen 47

All UniProt accessions (1): Q5JQC4

UniProt curated annotations — full annotation on UniProt →

Tissue specificity. Strongly expressed in testis, low expression in placenta, and very low expression in brain.

RefSeq proteins (1): NP_775842* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR028930CT47Family

Pfam: PF15623

UniProt features (14 total): compositionally biased region 9, region of interest 2, chain 1, sequence conflict 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5JQC4-F153.930.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 6 (showing top): chrXq24, MIR5696, MIR12123, MIR664A_3P, FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP, ZHOU_INFLAMMATORY_RESPONSE_LPS_UP

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

350 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CT47A11GPHRAB7ZAQ6952
CT47A11TAF11L5A0A1W2PP81654
CT47A11TAF11L4A0A1W2PPE2654
CT47A11TAF11L3A0A1W2PRV1654
CT47A11TAF11L2A6NLC8620
CT47A11CTAG2O75638616
CT47A11CT45A1Q5HYN5602
CT47A11MAGEA1P43355584
CT47A11A0A1W2PRN6A0A1W2PRN6544
CT47A11CT55Q8WUE5522
CT47A11PRR20AP86496522
CT47A11A0A1W2PQG5A0A1W2PQG5520
CT47A11SPANXA1Q9NS26507
CT47A11CSAG2Q9Y5P2507
CT47A11USP17L23D6RBM5506

IntAct

3 interactions, top by confidence:

ABTypeScore
CSAG2CAMK2Dpsi-mi:“MI:0914”(association)0.350
NXT2MYO1Gpsi-mi:“MI:0914”(association)0.350

BioGRID (15): CT47A3 (Positive Genetic), CT47A2 (Positive Genetic), CT47A6 (Positive Genetic), CT47A5 (Positive Genetic), CT47A1 (Positive Genetic), CT47A7 (Positive Genetic), CT47A11 (Positive Genetic), CT47A4 (Positive Genetic), CT47A10 (Positive Genetic), CT47A12 (Positive Genetic), CT47A9 (Positive Genetic), CT47A8 (Positive Genetic), CT47A6 (Negative Genetic), CT47A3 (Negative Genetic), CT47A1 (Affinity Capture-MS)

ESM2 similar proteins: A0A0U1RQG5, A1L429, A6NDE8, A6NER3, A6NGK3, E1AZ71, O08664, O60829, O75459, O76087, P0C2W7, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P52651, P62521, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q17QW4, Q28181, Q2T9P9, Q32PA2, Q4V321, Q4V326, Q5JQC4, Q5U2Y8, Q62100, Q63803, Q64256, Q6NT46, Q6X7S9, Q7Z2X7

Diamond homologs: A0A0U1RQG5, P0C2W7, Q5JQC4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

643 predictions. Top by Δscore:

VariantEffectΔscore
X:120933878:A:Cdonor_gain1.0000
X:120933881:TGA:Tdonor_gain1.0000
X:120936179:T:TAdonor_gain1.0000
X:120933881:TGAAC:Tdonor_gain0.9900
X:120933896:ACAT:Adonor_gain0.9900
X:120933897:CAT:Cdonor_gain0.9900
X:120933897:CATC:Cdonor_gain0.9900
X:120933899:T:TAdonor_gain0.9900
X:120933925:A:ACdonor_gain0.9900
X:120935272:CTT:Cacceptor_gain0.9900
X:120935277:T:Cacceptor_gain0.9900
X:120935277:T:TCacceptor_gain0.9900
X:120935306:C:CTacceptor_gain0.9900
X:120936160:AC:Adonor_gain0.9900
X:120936161:CC:Cdonor_gain0.9900
X:120936161:CCCT:Cdonor_gain0.9900
X:120935275:C:CCacceptor_gain0.9800
X:120935276:T:Cacceptor_gain0.9800
X:120936156:CCTTA:Cdonor_loss0.9700
X:120936157:CTTAC:Cdonor_loss0.9700
X:120936158:TTA:Tdonor_loss0.9700
X:120936159:TA:Tdonor_loss0.9700
X:120936160:A:AGdonor_loss0.9700
X:120936161:C:CAdonor_loss0.9700
X:120933896:A:ACdonor_gain0.9600
X:120933897:C:CCdonor_gain0.9600
X:120935270:GACTT:Gacceptor_gain0.9600
X:120935135:TC:Tdonor_gain0.9500
X:120935632:T:TGacceptor_gain0.9500
X:120935311:A:Cacceptor_gain0.9400

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 138 via entrez): RS111897421 (X:120933526 C>A), RS112187612 (X:120961549 T>C), RS1161215653 (X:120960524 TGTGGCTGG>T), RS1173923429 (X:120960523 C>A), RS1178078523 (X:120960530 T>C), RS1197669488 (X:120960565 C>T), RS1225955136 (X:120960538 C>G), RS1233264210 (X:120960545 T>C), RS1238535920 (X:120960571 G>A), RS1244521626 (X:120960502 C>A,T), RS1253712605 (X:120960478 G>A), RS1264478689 (X:120960559 C>T), RS1299893650 (X:120960541 C>T), RS1309004824 (X:120960437 G>A), RS1337478774 (X:120960530 TG>T,TGG)

Disease associations

OMIM: gene MIM:300592 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
butyraldehydeincreases expression1
Copper Sulfateaffects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.